The government committed to pay Sanofi and GlaxoSmithKline $2.1 billion to develop and make 100 million doses of coronavirus vaccine, HHS and the Department of Defense announced Friday (July 31), and Sanofi said more than half of the award is for the vaccine’s development. T
NON-SUBSCRIBER OPTIONS
FREE TRIAL | NEWSSTAND
Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.
Log in to access this content.
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.
© 2002-2020. Inside Washington Publishers | Contact Us